Evidence map›Paper›PMID 37043751›Full record

ArticleEuropean journal of public health2023

Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries.

Meritxell Mallafré-Larrosa, David Ritchie, Ginevra Papi, Isabel Mosquera, Keitly Mensah, Eric Lucas, Rikke Buus Bøje, Pia Kirkegaard, Berit Andersen, Partha Basu and 1 more

Abstract read
In one paragraph

Article in European journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Meritxell Mallafré-LarrosaAssociation of European Cancer Leagues (ECL), Brussels, Belgium.
David RitchieAssociation of European Cancer Leagues (ECL), Brussels, Belgium.
Ginevra PapiAssociation of European Cancer Leagues (ECL), Brussels, Belgium.
Isabel MosqueraEarly Detection, Prevention & Infections Branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon Cedex 07, France.
Keitly MensahEarly Detection, Prevention & Infections Branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon Cedex 07, France.
Eric LucasEarly Detection, Prevention & Infections Branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon Cedex 07, France.
Rikke Buus BøjeDepartment of Public Health Programmes, Randers Regional Hospital, University Research Clinic for Cancer Screening, Randers, Denmark.
Pia KirkegaardEarly Detection, Prevention & Infections Branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon Cedex 07, France.
Berit AndersenDepartment of Public Health Programmes, Randers Regional Hospital, University Research Clinic for Cancer Screening, Randers, Denmark.
Partha BasuEarly Detection, Prevention & Infections Branch, International Agency for Research on Cancer/World Health Organization (IARC), Lyon Cedex 07, France.
CBIG-SCREEN Consortium

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThis study aimed to investigate the status of cervical cancer screening (CCS) implementation in Europe by investigating national or regional policies towards broadening coverage of CCS amongst vulnerable subgroups of the population at high risk for CC.

methodsA web-based survey was conducted between September 2021 and February 2022 with CCS programme managers and experts to identify and rank six population subgroups at high risk considered most vulnerable to CC and to map existing policies that addressed the coverage of CCS towards population sub-groups at risk.

resultsA total of 31 responses were received from experts covering 22 European countries. The results of this survey suggest that whilst many countries identify lower coverage of CCS amongst population subgroups at high risk of CC as a public health problem, few countries have developed dedicated policies towards broadening coverage among these subgroups. The six countries who reported having done so were concentrated in the Northern or Western European regions, suggesting the existence of geographical disparities within the continent. A key challenge in this respect is the difficulty to categorize subgroups of the target population; many individuals are burdened by intersectionality thereby resting in multiple categories, which may hinder the effectiveness of interventions targeted to reach specific subgroups.

conclusionA greater clarity on the conceptualization of vulnerability can help countries to develop and subsequently implement strategies to increase coverage to subgroups of the target population currently underserved with regards to CCS.

Indexed as

Uterine Cervical NeoplasmsEarly Detection of CancerEuropeFemaleHumansMass ScreeningPolicyRisk Factors

Identifiers

PMID37043751
PMCPMC10234668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.